© 2006 American Public Health Association DOI: 10.2105/AJPH.2004.053413
Amy V. Groom is with the Program Operations Branch, Immunization Services Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga, and is field assigned to the Division of Epidemiology and Disease Prevention, Office of Public Health Support, Indian Health Service, Albuquerque, NM. James E. Cheek is with the Division of Epidemiology and Disease Prevention, Office of Public Health Support, Indian Health Service. Ralph T. Bryan is with the Office of Minority Health and Health Disparities, Office of Strategy and Innovation, Office of the Director, Centers for Disease Control and Prevention, and is field assigned to the Division of Epidemiology and Disease Prevention, Office of Public Health Support, Indian Health Service. Correspondence: Requests for reprints should be sent to Ralph T. Bryan, MD, OMHD/OSI/OD, Centers for Disease Control and Prevention, c/o Indian Health Service, Division of Epidemiology and Disease Prevention, 5300 Homestead Rd NE, Albuquerque, NM 87110 (e-mail: rrb2{at}cdc.gov).
Objectives. We determined the effect of national vaccine shortages on coverage with 4 doses of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine for American Indian/Alaska Native (AIAN) children. Methods. Data on DTaP coverage for children aged 19 to 27 months were abstracted from Indian Health Service (IHS) immunization reports. Coverage with the fourth DTaP dose (DTaP4) was compared for different periods to determine coverage levels before, during, and after the shortage. Data were stratified geographically to determine regional variation. Results. AIAN children experienced a significant decline (14.8%) in DTaP4 coverage during the shortage. Considerable variation was seen among IHS regions (declines ranged from 4.5% to 26.5%). Conclusions. AIAN children included in IHS immunization reports experienced a greater decline in DTaP4 coverage during the shortage than the decline reported nationally for children receiving vaccine at public clinics (14.8% vs 6%). Variations in the decline in coverage highlight possible inequities in vaccine supply and distribution and in implementation of vaccine shortage recommendations. We must identify ways to ensure more equitable vaccine distribution and consistent implementation of vaccine recommendations to protect all children from vaccine-preventable diseases. This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||